Last updated on April 2018

Trial to Evaluate the Safety ofTalimogene Laherparepvec Injected Into Liver Tumors Alone and in Combination With Systemic Pembrolizumab


Brief description of study

This is a phase 1b/2, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec injected intrahepatically into liver tumors with known progression alone and in combination with systemic IV administration of pembrolizumab, in subjects with non-HCC liver metastases from BC, CRC, GEC, melanoma, NSCLC, RCC, and subjects with HCC. The study consists of 2 parts and 2 groups, and Part 2 includes 2 stages. The objective of Part 1 is to evaluate the safety of intrahepatic injection of talimogene laherparepvec into liver tumors alone and in combination with systemically administered pembrolizumab for the non-HCC (Group A) and HCC (Group B) cohorts separately. Part 2 consists of 2-stage design to evaluate the efficacy and safety of talimogene laherparepvec in combination with systemic pembrolizumab. Efficacy and safety will be evaluated in each of the six non-HCC tumor types from Group A separately. Similarly, the efficacy and safety of the combination treatment will be determined for Group B HCC subjects.

Clinical Study Identifier: NCT02509507

Contact Investigators or Research Sites near you

Start Over

Amgen Call Center

Research Site
Los Angeles, CA United States
  Connect »

Amgen Call Center

Research Site
Louisville, KY United States
  Connect »

Amgen Call Center

Research Site
Saint Louis, MO United States
  Connect »

Amgen Call Center

Research Site
New Brunswick, NJ United States
  Connect »

Amgen Call Center

Research Site
Barcelona, Spain
  Connect »

Amgen Call Center

Research Site
Madrid, Spain
  Connect »

Amgen Call Center

Research Site
Geneva 14, Switzerland
  Connect »

Amgen Call Center

Research Site
Lausanne, Switzerland
  Connect »

Amgen Call Center

Research Site
Winterthur, Switzerland
  Connect »

Amgen Call Center

Research Site
Edegem, Belgium
  Connect »

Amgen Call Center

Research Site
Gent, Belgium
  Connect »